Dabrafenib is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is approved to treat melanoma. It is also being studied in the treatment of other types of cancers, including multiple myeloma.

SparkCures ID 113
Developed By GlaxoSmithKline
Generic Name Dabrafenib
Additional Names Tafinlar
Treatment Classifications
  • Kinase Inhibitor

Clinical Trials


There are no resources, links or videos to display for this treatment.